DNA & Genetics AstraZeneca Plans $2 Billion Biomanufacturing Investment in MarylandBy adminNovember 27, 20250 Credit: Reptile8488/Getty Images AstraZeneca says it expects to invest $2 billion to expand its long-standing manufacturing footprint in Maryland. This…
Longevity AI-powered gene editing startup lands $555m AstraZeneca dealBy adminOctober 6, 20250 Algen Biotechnologies is combining CRISPR and AI to decode the root cause of disease and accelerate new drug development. In…
